Unknown

Dataset Information

Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients.


ABSTRACT:

Purpose

Early-stage non-small cell lung cancer (NSCLC) is potentially curable, however, many patients develop recurrent disease. Therefore, identification of biomarkers that can be used to predict patient's risk of recurrence and survival is critical. Genetic polymorphisms or single-nucleotide polymorphisms (SNP) of DNA- and histone-modifying genes, particularly those of O(6)-methylguanine DNA-methyltransferase (MGMT), have been linked to an increased risk of lung cancer as well as treatment outcomes in other tumors.

Experimental design

We assessed the association of 165 SNPs in selected epigenetic enzyme genes, DNA methyltransferases, and methyl-CpG-binding proteins with cancer recurrence in 467 patients with stage I or II NSCLC treated with either surgery alone (N = 340) o

SUBMITTER: Wagner KW 

PROVIDER: S-EPMC3373176 | biostudies-literature | 2012 Jan

REPOSITORIES: biostudies-literature